Providing comprehensive genetic testing using a single method approach that is based on whole-genome sequencing
Genomic Unity testing uses a single method for the detection of multiple types of variants to provide one, unified clinical report. PCR-free whole genome sequencing is paired with in-silico analysis to identify small sequence changes, large structural variants, mitochondrial variants, and tandem repeat expansions within a single sample. A complete analysis can be ordered directly, or a more targeted analysis can be selected followed by reflexing up to the complete analysis in case no initial results are identified.
Total Funding: $18 M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2C
Company Size: 26 to 50
Founded: 2014
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at VariantYX
Assistant Quality Assurance (QA)
Framingham, Massachusetts
Software Engineer
Framingham, Massachusetts
Medical/Clinical Genetic Review Specialist – Managed Care
Framingham, Massachusetts
Clinical Variant Scientist
Framingham, Massachusetts
VariantYX - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups VariantYX - Manage Profile